CoreAge Rx vs OrderlyMeds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and OrderlyMeds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
OrderlyMeds
FDA warning letter, June 2026 — issued to OrderlyMeds LLC dba OrderlyMeds. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 60 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make OrderlyMeds a bad call — it's best for people starting or transferring compounded treatment who confirm the applicable offer, full payment and multi-month cancellation conditions. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | OrderlyMeds |
|---|---|---|
| Brief Score | 94/100 (A) | 60/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Starter: $149 upfront for two months New-customer lowest-dose starter; transfer $224/two months. Returning/current-user monthly rate $149. Exact selected dose and supply unconfirmed. No membership fee advertised. FAQ low month-to-month wording needs clarification; multi-month cancellation is separately qualified. Full price detailsCompounded semaglutide injection offered; complete selected-prescription quote unknown; new-customer lowest-dose starter $149 paid upfront for two months, transfer offer $224 for two months, returning/current-user monthly rate $149 |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Starter: $299 upfront for two months New-customer lowest-dose starter; transfer $449/two months. Returning/current-user monthly rate $299. Complete selected prescription quote unconfirmed. Provider support/supplies included as advertised. Cancellation ends at prescription finalization with separate multi-month conditions; prescribing denial brings a refund. Full price detailsCompounded tirzepatide injection offered; complete selected-prescription quote unknown; new-customer lowest-dose starter $299 paid upfront for two months, transfer offer $449 for two months, returning/current-user monthly rate $299 |
| Coverage | US only; restrictions by state, confirmed at intake | Licensed provider network advertised in all 50 states; clinical suitability, pharmacy fulfillment and any required live visit remain patient-specific |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
OrderlyMeds: Two-month starters: $149 semaglutide/$299 tirzepatide; transfers $224/$449; returning monthly rates $149/$299. New-customer and dose conditions apply; confirm multi-month cancellation terms.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.